Skip to the content
Search
Beyond Type 2
Menu
BEYOND TYPE 2
Show sub menu
About
Our Story
Founding Partners
Board of Directors
Leadership Council
The Team
Join Us
Contact
Diabetes
Type 1 Info
Type 2 Info
Prediabetes Info
Forms of Diabetes
Newly Diagnosed
Diabetes Management
Pregnancy and Diabetes
Resources
GetInsulin.org
Insulin for T2D
Diabetes Management
Understanding T2D
Exercise
Food
Heart Health
Mental Health
Continuous Glucose Monitoring (CGM)
Veterans with Diabetes
Beyond Type 2 Advocacy
Stories
Diabetes News
Type 2 Stories
Community
Beyond Type 2 App
Marathon Team
En Español
Search
Tag:
SGLT-2
Mark Cuban’s Cost Plus Drugs Offers New SGLT-2 Medication for Type 2 Diabetes
Brenzavvy is the latest SGLT-2 medication for type 2 diabetes to be added to Mark Cuban’s Cost Plus Drug company’s product lineup, helping improve the affordability of the drug.
Mark Cuban’s Cost Plus Drugs Makes Diabetes Products More Affordable
Mark Cuban's Cost Plus Drugs Company just announced that they offer Janssen's Invokana, Invokamet and Invokamet XR for type 2 diabetes.
Dapagliflozin May Reduce the Onset of Type 2 Diabetes
Research presented at the American Diabetes Association's 80th Scientific Sessions revealed that the SGLT-2 Inhibitor, dapagliflozin, may reduce the onset of Type 2 diabetes when used in patients...
FDA Approves Invokana to Treat Diabetic Kidney Disease
On Monday, September 30, 2019, the U.S. Food and Drug Administration (FDA) approved a new indication for the Janssen Pharmaceutical Companies of Johnson & Johnson's INVOKANA (canagliflozin) t...
Medication Options for Type 2 Diabetes
There are so many treatment options for type 2 diabetes today—it can be a little overwhelming. But it’s really important to find what works for you!